Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Cephalon to acquire Mepha AG

Cephalon to acquire Mepha AG

2nd February 2010

Cephalon this week announced its plans to acquire the privately held Swiss firm Mepha AG, a deal which also includes the organisation’s subsidiaries.

Mepha, which specialises in innovative dosage formulations and deals in both generic and branded generic products, will be bought for 622.5 million Swiss francs (369.7 million pounds).

The transaction, which is set to conclude within the next ten to 12 weeks, will serve to diversify Cephalon’s business mix and will double the size of its international operations.

Additionally, it provides an existing platform from which to launch new products in emerging markets.

Frank Baldino, chairman and chief executive officer of Cephalon, said: “The addition of Mepha will transform our international business overnight, expanding our ability to serve global markets and reach patients in new territories for the first time.”

Earlier this week, Cephalon revealed that it has promoted three of its executives – Kevin Buchi, Wilco Groenhuysen and Alain Aragues.

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.